Form 4: Moderna's Chief Legal Officer Reports Stock Transactions
SEC Form 4 Filing
Shannon Thyme Klinger, Moderna's Chief Legal Officer, reported the acquisition and disposal of company stock, including transactions to cover tax withholding obligations.
Summary
- On August 27, 2024, Shannon Thyme Klinger, Moderna's Chief Legal Officer, reported transactions involving Moderna common stock.
- These transactions included the conversion of 2,652 restricted stock units (RSUs) into common stock.
- Klinger also sold 1,319 shares on August 28, 2024, at a price of $79.3949 per share to cover tax withholding obligations related to the vesting of RSUs.
- Following these transactions, Klinger beneficially owns 17,280 shares of Moderna common stock and 5,305 restricted stock units.
Sentiment
Score: 5
Explanation: The sentiment is neutral as the filing reflects routine transactions related to executive compensation and tax obligations.
Industry Context
Form 4 filings are routine disclosures required by the SEC for corporate insiders, providing transparency into their trading activities. These filings are closely watched by investors to gauge management's sentiment and confidence in the company.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 08/27/2024 | Date of RSU conversion to common stock. |
| 08/28/2024 | Date of stock sale to cover tax withholding. |
| 08/29/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.